Bonky Soft Cap.
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- Category
- Pharmaceuticals
Yuyu Pharma., Inc.
- Country / Year Established
-
South Korea
/
- Business type
- Others
- Verified Certificate
-
16
| Product name | Bonky Soft Cap. | Certification | - |
|---|---|---|---|
| Category | Pharmaceuticals | Ingredients | - |
| Keyword | - | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
Features
- Composition/Strength: calcitriol 0.25 mcg
- Dosage: 1 capsule, twice a day
- Calcirtiol is the most active known form of vitamin D3 in stimulating intestinal calcium transport
- The beneficial effect of Bonky in renal osteodystrophy appears to result from correction of hypocalcemia and secondary hyperparaphyroidism.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Seung Pil, Yu
- Address
- Yuyu Bldg., 197, Dongho-ro, Jung-gu, Seoul, Korea
- Product Category
- Herbal Medicine,Pharmaceuticals
- No. of Total Employees
- 101-500
- Company introduction
-
Yuyu Pharma., Inc. is one of the leading innovators and marketers of pharmaceutical products with over 250 employees nationwide in Korea.
Yuyu's mission is to improve the quality life by providing the most effective and safe medical treatments in the market.The company has kept this promise since its establishment in 1941 and will continue to do so with the introduction of new generation of medicines.
Recently, Yuyu has begun to focus more on how to serve the aging population, as people are living longer and searching for ways to live a ealthier life. This has led us to be a specialist in the fields of degenerative neurological disease, osteoporosis and cerebrovascular diseases. Yuyu's treatment in these three areas has proven to be fruitful and we will continue to focus in these therapeutic categories.In order to increase out area of expertise, we also have plans to further expand out presence in the field of gastrointestinal diseasea and antibiotics.
- Main Product
